MedTrace Logo

Effect of AN-PEP Enzyme on Gluten Digestion

NCT01335503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-08-13

No results posted yet for this study

Summary

The aim is to demonstrate how fast and to what extent AN-PEP can degrade gluten in vivo in the stomach and how much gluten enters the small intestine. A second question is whether the caloric density of a meal can influence the efficacy of AN-PEP breakdown.

Conditions

  • Gluten Digestion

Interventions

DIETARY_SUPPLEMENT

AN-PEP

Endoprotease enzyme (AN-PEP)

Sponsors & Collaborators

  • DSM Food Specialties

    lead INDUSTRY

Principal Investigators

  • Ad Masclee, Prof Dr · Maastricht University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01335503 on ClinicalTrials.gov